In vitro biocompatibility studies with the experimental anticancer agent BIBX1382BS

International Journal of Pharmaceutics

Volumn 194, Issue 2, 2000, Pages 261-267

  Nuijen, B ^a   Bouma, M ^a   Henrar, R E C ^b   Brauns, U ^c   Bette, P ^c   Bult, A ^d   Beijnen, J H ^a,d  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b NDDO Oncology   (Netherlands)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

BIBX1382BS; Biocompatibility; FB ratio; Hemolysis; Precipitation

Indexed keywords

ANTINEOPLASTIC AGENT; BIBX 1382BS; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PYRIMIDO[5,4 D]PYRIMIDINE 2,8 DIAMINE N8 (3 CHLORO 4 FLUOROPHENYL) N2 (1 METHYL 4 PIPERIDINYL); PYRIMIDO[5,4 D]PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CANCER INHIBITION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG SCREENING; HEMOLYSIS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; HEMOLYSIS; HUMANS; ORGANIC CHEMICALS; PRECIPITATION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0033963424     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00389-0     Document Type: Article

References (9)

1. Davio S.R., McShane M.M., Kakuk T.J., Zaya R.M., Cole S.L. Precipitation of the renin inhibitor ditekiren upon iv infusion; in vitro studies and their relationship to in vivo precipitation in the cynomolgus monkey. Pharm. Res. 8:1991;80-83.
2. Gupta S.L., Patel J.P., Jones D.L., Partipilo R.W. Parenteral formulation development of renin inhibitor Abott-72517. J. Parenter. Sci. Technol. 48:1994;86-91.
3. Krzyzaniak J.F., Yalkowsky S.H. Lysis of human red blood cells. 2. Effect of contact time on surfactant-induced hemolysis. J. Pharm. Sci. Technol. 52:1998;66-69.
4. Krzyzaniak J.F., Alvarez Núñez F.A., Raymond D.M., Yalkowsky S.H. Lysis of human red blood cells. 4. Comparison of in vitro and in vivo hemolysis data. J. Pharm. Sci. 86:1997;1215-1217.
5. Krzyzaniak J.F., Raymond D.M., Yalkowsky S.H. Lysis of human red blood cells. 2. Effect of contact time on cosolvent induced hemolysis. Int. J. Pharm. 152:1997;193-200.
6. Li P., Vishnuvajjala R., Tabibi S.E., Yalkowsky S.H. Evaluation of in vitro precipitation methods. J. Pharm. Sci. 87:1998;196-199.
7. Ward G.H., Yalkowsky S.H. Studies in phlebitis VI: dilution-induced precipitation of amiodarone HCl. J. Parenter. Sci. Technol. 47:1993;161-165.
8. Ward G.H., Yalkowsky S.H. Studies in phlebitis V: hemolysis as a model for phlebitis. J. Parenter. Sci. Technol. 47:1993;44-46.
9. Yalkowsky S.H., Valvani S.C., Johnson B.W. In vitro method for detecting precipitation of parenteral formulations after injection. J. Pharm. Sci. 72:1983;1014-1017.